GC Biopharma Corp - Company Profile

Powered by

All the sales intelligence you need on GC Biopharma Corp in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how GC Biopharma Corp fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with GC Biopharma Corp.

Back to companies

GC Biopharma Corp: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

GC Biopharma Corp (GC Biopharma), formerly GC Pharma, provides plasma protein therapeutics and vaccines. The company develops, manufactures, and markets plasma-derived products, including albumin, immunoglobulin, and antithrombin. It also produces vaccines to prevent infectious diseases and a portfolio of prescription medicines addressing cardiovascular, respiratory, central nervous system, gastrointestinal, immunology, musculoskeletal, genetic, metabolic, and hematological disorders. In the consumer health segment, GC Biopharma offers over-the-counter products such as anti-inflammatory medicines, anti-allergy treatments, and other self-care options. The company’s research and development activities focus on advancing new therapies for cancer, tuberculosis, and Hunter syndrome, as well as additional unmet medical needs. GC Biopharma is headquartered Yongin, Gyeonggi-do, South Korea.

 Gain a 360-degree view of GC Biopharma Corp and make more informed decisions for your business Gain a 360-degree view of GC Biopharma Corp and make more informed decisions for your business Learn more
Headquarters South Korea
Address 107, Ihyeon-Ro 30beon-Gil, Giheung-Gu, Yongin-si, 16924
Website www.gcbiopharma.com
Telephone 82 31 2609300
No of Employees 2,351
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange 006280 (KRX)
Revenue (2024) $1.4B 18.5% (2024 vs 2023)
EPS XYZ
Net Income (2024) XYZ 82.2% (2024 vs 2023)
Market Cap* $1.1B
Net Profit Margin (2024) XYZ 85.3% (2024 vs 2023)
* As of and is in US$
View GC Biopharma Corp financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

GC Biopharma Corp premium industry data and analytics

140+

Clinical Trials

Determine GC Biopharma Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

70+

Pipeline Drugs

Identify which of GC Biopharma Corp’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

70+

Catalyst Calendar

Proactively evaluate GC Biopharma Corp’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

60+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for GC Biopharma Corp’s relevant decision makers and contact details.

60+

Marketed Drugs

Understand GC Biopharma Corp’s commercialized product portfolio to stay one step ahead of the market.

11+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

1

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

Products and Services

Products
Prescription Drugs
Over-The-Counter Drugs
Quasi Drugs
XYZ
XYZ
XYZ
Understand GC Biopharma Corp portfolio and identify potential areas for collaboration Understand GC Biopharma Corp portfolio and identify potential areas for collaboration Learn more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2026 Contracts/Agreements In September, the company was selected as the lead research institution to develop an AI-based Vaccine Manufacturing Variability Control and Intelligent Quality Management System.
2026 Regulatory Approval In September, the company received approval from the Ministry of Food and Drug Safety to begin Phase 2 domestic trials of its COVID-19 mRNA vaccine candidate GC4006A.
2026 Regulatory Approval In September, the company secured approval from the Ministry of Food and Drug Safety for the Phase 2/3 clinical trial protocol of its highly immunogenic influenza vaccine candidate, GC3114B.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Learn more
Image for loader

Competitor Comparison

Key Parameters GC Biopharma Corp Yuhan Corp Huons Global Co Ltd Suheung Capsule Co Ltd Jeil Pharmaceutical Co Ltd
Headquarters South Korea South Korea South Korea South Korea South Korea
City Yongin-si Seoul Seongnam Cheongju Seoul
State/Province - - - - Seoul
No. of Employees 2,351 1,594 541 727 978
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Heo Eun-cheol Chief Executive Officer; Director Executive Board - 54
Shin Woong Head-Quality Management; Director; Head-Operations Division Executive Board 2023 54
Cha Gyeong-il Director; Head-MSAT Division; Head-R&D Sector Executive Board - 51
Lee Woo-jin Global Business Division; Director Executive Board 2018 57
Jeong Jae-wook Head - R&D Division; Director Executive Board 2023 62
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into GC Biopharma Corp key executives to enhance your sales strategy Gain insight into GC Biopharma Corp key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?